
Sign up to save your podcasts
Or
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.7
3535 ratings
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
245 Listeners
192 Listeners
1,891 Listeners
514 Listeners
413 Listeners
246 Listeners
309 Listeners
889 Listeners
41 Listeners
997 Listeners
14 Listeners
41 Listeners
42 Listeners
415 Listeners
677 Listeners
336 Listeners
263 Listeners
613 Listeners
34 Listeners
7 Listeners
10 Listeners
12 Listeners
5 Listeners
4 Listeners
22 Listeners
25 Listeners
8 Listeners
184 Listeners
5 Listeners
145 Listeners
14 Listeners
28 Listeners
33 Listeners
3 Listeners